U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866691) titled 'Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide' on March 04.
Brief Summary: The purpose of this study is to assess the incidence of early post-traumatic seizures. The study will also assess the benefit of lacosamide compared to levetiracetam in regards to agitation and behavioral adverse effects in patients with moderate to severe traumatic brain injury requiring seizure prophylaxis.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Traumatic Brain Injury
Intervention:
DRUG: levetiracetam
levetiracetam 1000 mg intravenously or by mouth twice daily for a total of 7 days
DRUG:...